Castle Biosciences (CSTL) Current Leases (2021 - 2026)

Castle Biosciences (CSTL) has 6 years of Current Leases data on file, last reported at $1.3 million in Q1 2026.

• Quarterly Current Leases fell 12.61% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 12.61% YoY) and the FY2025 annual result came in at $1.3 million, down 20.42% from the prior year.
• Current Leases slipped to $1.3 million in Q1 2026 per CSTL's latest filing, from $1.3 million in the prior quarter.
• The five-year high for Current Leases was $2.0 million in Q2 2023, with the low at $1.1 million in Q3 2023.
• Average Current Leases over 5 years is $1.4 million, with a median of $1.4 million recorded in 2025.
• Year-over-year, Current Leases jumped 62.35% in 2023 and plunged 37.64% in 2024.
• Castle Biosciences' Current Leases stood at $1.8 million in 2022, then sank by 36.02% to $1.1 million in 2023, then surged by 46.44% to $1.7 million in 2024, then retreated by 20.42% to $1.3 million in 2025, then decreased by 5.36% to $1.3 million in 2026.
• Business Quant data shows CSTL's Current Leases at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.